Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Quetiapine and Paediatric Psychiatrica: Evidence or Diffidence?
1
x
$
30.00
Escitalopram: A Second-Generation SSRI
1
x
$
0.00
Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
1
x
$
30.00
Ultrasonically Determined Thyroid Volume in Individuals with Bipolar Disorder on Lithium Prophylaxis Compared with Healthy Controls
1
x
$
30.00
Farmacoterapias: Lineamientos del concenso de expertos para el tratamiento farmacológico del trastorno bipolar: una nueva herramienta terapéutica
1
x
$
0.00
Switching to Duloxetine Remits Ziprasidone - Edward C. Lauterbach
1
x
$
30.00
Paroxetine Use in Medically Ill Patients
1
x
$
30.00
VOL 3 No. 1 Full Issue - January 2001
1
x
$
20.00
Takotsubo Cardiomyopathy Related to Duloxetine-Atomoxetine Combination in an Adolescent with ADHD and Comorbid GAD
1
x
$
30.00
Clozapine Induced Hypertension and its Association with Autonomic Dysfunction
1
x
$
30.00
View Cart
Checkout
Home
Bryun EA
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
$
30.00
Add to cart
Details
Impact of the Omics-Based Biomarkers on the Mirtazapine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
